Issued Patents All Time
Showing 26–50 of 125 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10919974 | Antibodies for treatment of cancer expressing claudin 6 | Ugur Sahin, Michael Koslowski, Korden Walter, Stefan Woll, Maria Kreuzberg +3 more | 2021-02-16 |
| 10844133 | Cancer therapy using CLDN6 target-directed antibodies in vivo | Ugur Sahin, Michael Koslowski, Korden Walter, Maria Kreuzberg, Sylvia Luxen | 2020-11-24 |
| 10813996 | Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer | Ugur Sahin, Rita Mitnacht-Kraus, Stefan Jacobs, Magdalena Jadwiga Utsch, Cornelia Adriana Maria Heinz +1 more | 2020-10-27 |
| 10745477 | Antibodies specific for claudin 6 (CLDN6) | Ugur Sahin, Michael Koslowski, Korden Walter, Stefan Woll, Maria Kreuzberg +2 more | 2020-08-18 |
| 10738108 | Monoclonal antibodies against claudin-18 for treatment of cancer | Ugur Sahin, Dirk Usener, Stefan Fritz, Christoph Uherek, Gunda Brandenburg +3 more | 2020-08-11 |
| 10724103 | Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapy | Ugur Sahin, Sandra Schneider, Gerd Helftenbein, Volker Schlüter, Dirk Usener +2 more | 2020-07-28 |
| 10717780 | Agents for treatment of claudin expressing cancer diseases | Ugur Sahin, Christiane Stadler, Julia Holland, Hayat Bähr-Mahmud, Tim Beissert +4 more | 2020-07-21 |
| 10604568 | Diagnosis and therapy of cancer involving cancer stem cells | Ugur Sahin, Korden Walter, Meike Wagner, Maria Kreuzberg, Sabine Hacker +1 more | 2020-03-31 |
| 10596256 | Monoclonal anti-GT 468 antibodies for treatment of cancer | Ugur Sahin, Michael Koslowski, Rita Mitnacht-Kraus | 2020-03-24 |
| 10526387 | Tumor vaccination involving a humoral immune response against self-proteins | Thorsten Klamp, Ugur Sahin, Michael Koslowski, Thomas Hiller, Jens Schumacher | 2020-01-07 |
| 10414824 | Genetic products differentially expressed in tumors and the use thereof | Ugur Sahin, Michael Koslowski | 2019-09-17 |
| 10370423 | Claudin-6-specific immunoreceptors and T cell epitopes | Ugur Sahin, Petra Simon, Tana Omokoko, Holger Hoff, Ralf-Holger Voss +3 more | 2019-08-06 |
| 10314890 | Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer | Ugur Sahin, Rita Mitnacht-Kraus, Stefan Woll, Stefan Jacobs, Cornelia Adriana Maria Heinz | 2019-06-11 |
| 10302647 | Identification of surface-associated antigens for tumor diagnosis and therapy | Ugur Sahin, Michael Koslowski, Gerd Helftenbein, Dirk Usener, Volker Schlüter | 2019-05-28 |
| 10253373 | Identification of tumor-associated markers for diagnosis and therapy | Ugur Sahin, Michael Koslowski | 2019-04-09 |
| 10233253 | Antibodies for treatment of cancer expressing claudin 6 | Ugur Sahin, Michael Koslowski, Korden Walter, Stefan Woll, Maria Kreuzberg +3 more | 2019-03-19 |
| 10174104 | Monoclonal antibodies against claudin-18 for treatment of cancer | Ugur Sahin, Dirk Usener, Stefan Fritz, Christoph Uherek, Gunda Brandenburg +3 more | 2019-01-08 |
| 10137195 | Therapy involving antibodies against Claudin 18.2 for treatment of cancer | Ugur Sahin | 2018-11-27 |
| 10125196 | Monoclonal antibodies for treatment of cancer | Ugur Sahin, Michael Koslowski | 2018-11-13 |
| 10117918 | Antigen-specific T cell receptors and T cell epitopes | Ugur Sahin, Petra Simon, Tana Omokoko | 2018-11-06 |
| 10106800 | Modification of RNA, producing an increased transcript stability and translation efficiency | Ugur Sahin, Silke Holtkamp, Sebastian Kreiter | 2018-10-23 |
| 10093736 | Agents for treatment of claudin expressing cancer diseases | Ugur Sahin, Christiane Stadler, Julia Holland, Hayat Bähr-Mahmud, Tim Beissert +4 more | 2018-10-09 |
| 10053512 | Antibodies against claudin 18.2 useful in cancer diagnosis | Ugur Sahin, Rita Mitnacht-Kraus, Stefan Woll | 2018-08-21 |
| 10036753 | Identification of surface-associated antigens for tumor diagnosis and therapy | Ugur Sahin, Michael Koslowski, Gerd Helftenbein, Dirk Usener, Volker Schlüter | 2018-07-31 |
| 10022444 | Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer | Ugur Sahin, Rita Mitnacht-Kraus, Stefan Jacobs, Magdalena Jadwiga Utsch, Cornelia Adriana Maria Heinz +1 more | 2018-07-17 |